{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:13:14Z","timestamp":1793812394362,"version":"4.6.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>SSTR2a, a member of the somatostatin receptor family, has been used as a diagnostic marker of meningioma. However, the expression of SSTR2a in follicular dendritic cells (FDCs) and their related tumors has been poorly characterized. This study aimed to assess the potential diagnostic utility of measuring SSTR2a immunohistochemically in FDCs and their related tumors. We evaluated whole-tissue sections from 182 cases including 83 lymphoid reactive follicular hyperplasias, 17 follicular lymphomas, 18 follicular dendritic cell sarcomas (FDCSs), 6 inflammatory pseudotumor-like FDCSs, and 58 other histologic mimics. Immunohistochemistry for SSTR2a and other FDC markers (CD21, CD23, CD35, clusterin, and podoplanin) were performed in all 182 cases. Diffuse membrane immunoreactivity for SSTR2a in FDCs was observed in 100% of follicular lymphoma and FDCS cases and in 96.4% of the reactive follicular hyperplasias cases. Notably, the positive rate of SSTR2a in FDCSs was higher than that of CD21 (88.9%), CD23 (77.8%), CD35 (94.4%), clusterin (55.6%), and podoplanin (94.4%). All inflammatory pseudotumor-like FDCSs were negative for SSTR2a. The histologic mimics were negative for SSTR2a, except for 1 leiomyosarcoma case that showed focal (~10%) positive expression for SSTR2a. Overall, our findings indicate that SSTR2a is a highly sensitive and diagnostically useful marker for FDCs and FDCSs. Furthermore, immunohistochemistry for SSTR2a may be helpful to distinguish FDCSs from inflammatory pseudotumor-like FDCSs and other histologic mimics. Moreover, our findings suggest that SSTR2a may be a potential therapeutic target for treatment of FDCSs.<\/jats:p>","DOI":"10.1097\/pas.0000000000001205","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T19:29:23Z","timestamp":1545938963000},"page":"374-381","source":"Crossref","is-referenced-by-count":25,"title":["SSTR2a Is a Useful Diagnostic Marker for Follicular Dendritic Cells and Their Related Tumors"],"prefix":"10.1097","volume":"43","author":[{"given":"Li-Li","family":"Tao","sequence":"first","affiliation":[{"name":"Department of Pathology, Peking University Shenzhen Hospital, Shenzhen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hua","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine"},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University Shenzhen Hospital, Shenzhen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University Shenzhen Hospital, Shenzhen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University Shenzhen Hospital, Shenzhen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2012.00292","article-title":"Follicular dendritic cells in health and disease","volume":"3","author":"EI Shikh","year":"2012","journal-title":"Front Immunol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"926295","DOI":"10.1155\/2013\/926295","article-title":"Peptide receptor targeting in cancer: the somatostatin paradigm","volume":"2013","author":"Barbieri","year":"2013","journal-title":"Int J Pept"},{"key":"R4-20230922","article-title":"Importance of immunohistochemical detection of somatostatin receptors","author":"Zalatnai","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jnen\/nlx008","article-title":"Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics","volume":"76","author":"Boulagnon-Rombi","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3748\/wjg.v16.i20.2504","article-title":"Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma","volume":"16","author":"Li","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ajh.20852","article-title":"Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature","volume":"82","author":"Soriano","year":"2007","journal-title":"Am J Hematol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/7P8U659JBJCV6EEU","article-title":"Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors","volume":"128","author":"Yu","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.pas.0000112536.76973.7f","article-title":"Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors","volume":"28","author":"Grogg","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anndiagpath.2016.05.003","article-title":"Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1","volume":"23","author":"Agaimy","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2141.2008.07218.x","article-title":"Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression","volume":"142","author":"Miyazaki","year":"2008","journal-title":"Br J Haematol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000478-200106000-00003","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association","volume":"25","author":"Cheuk","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1309\/BUWNMG5RV4D09YYH","article-title":"Inflammatory pseudotumor of the spleen associated with clonal Epstein-Barr virus genome. Case report and review of the literature","volume":"120","author":"Lewis","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clinimag.2014.12.021","article-title":"Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature review","volume":"39","author":"Bui","year":"2015","journal-title":"Clin Imaging"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1200\/jco.2014.32.15_suppl.4107","article-title":"Progression-free survival (PFS) with lanreotide autogel\/depot (LAN) in enteropanccreatic NETS patients: the CLARINET extension study. ASCO 2014 Annual Meeting (abstract #)","volume":"32","author":"Caplin","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201903000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:44:48Z","timestamp":1695422688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201903000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001205","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}